Molcure Inc.

We are an #AI company focusing on accelerating #DrugDiscovery & design.

[Molcure Inc. @molcure]

We’re thrilled to announce that MOLCURE has entered into a multi-year strategic research agreement with Boehringer Ingelheim! Together, we’ll discover innovative antibody therapeutics across multiple targets using our AI-driven platform.
https://t.co/uC6jiar4ka

[Molcure Inc. @molcure]

詳細：https://t.co/SBjUGomxrC

[Molcure Inc. @molcure]

6/22-6/25、サンディエゴで開催される#BIO2026に、当社CEO/CSOの玉木が参加します！ミーティングをご希望の方は、イベント公式Partnaring Systemからご連絡ください！
↓詳細はスレッドに

[Molcure Inc. @molcure]

Info: https://t.co/SBjUGomxrC

[Molcure Inc. @molcure]

Meet MOLCURE at #BIO2026 in San Diego, June 22-25! Our CEO/CSO, Satoshi Tamaki, is ready to explore partnerships. Connect with us via the official partnering system!
Link in thread.

[Molcure Inc. @molcure]

詳細・お申し込み：
https://t.co/q0WQZIgwZL

[Molcure Inc. @molcure]

6/16（火）15:00より、イルミナ社 (@illuminakk) 主催のウェビナーに当社Chief Innovation Officerの小川が登壇します！イルミナ社製NGSと当社独自のAI技術を活用した超高性能抗体取得の実例を交えながら、AIが切り拓く抗体創薬の最前線をご紹介します。
↓記事リンクはスレッドに

[Molcure Inc. @molcure]

Details & registration:
https://t.co/q0WQZIgwZL

[Molcure Inc. @molcure]

On June 16 (Tue) from 3:00 p.m. JST, our Chief Innovation Officer, Ogawa, will speak at an @illuminakk webinar (in Japanese)! He will share case studies where MOLCURE’s proprietary AI technologies and Illumina’s NGS platforms are combined to discover high-performance antibodies.

[Molcure Inc. @molcure]

詳細：
https://t.co/jidhZd6nr8

[Molcure Inc. @molcure]

日経xTECH (@NIKKEIxTECH) に、当社CEO兼CSO 玉木のインタビュー記事が掲載されました。ぜひご覧ください！

記事タイトル：独自LLMでプロテインAIに挑むMOLCURE、「捨てていたデータも実は重要」

↓記事リンクはスレッドに

[Molcure Inc. @molcure]

Full article (in Japanese):
https://t.co/jidhZd6nr8

[Molcure Inc. @molcure]

Nikkei xTECH (@NIKKEIxTECH) has featured an interview with MOLCURE’s CEO and CSO, Satoshi Tamaki! Link in thread.

[Molcure Inc. @molcure]

↓詳細はこちら
https://t.co/HpMFA7ljKB

[Molcure Inc. @molcure]

日立製作所とMOLCUREは、オープンイノベーションによるAI創薬の加速を目指し、日立製作所が開発中の「秘匿AI基盤」のサービス提供に向けて両社の協創を本格化することを共同で発表しました！

[Molcure Inc. @molcure]

Details: https://t.co/anUhZuQoqy

[Molcure Inc. @molcure]

Hitachi and MOLCURE are pleased to jointly announce the full-scale launch of their co-creation toward providing services based on Hitachi’s Confidential AI Platform – designed to accelerate AI-driven drug discovery through open innovation!

[Molcure Inc. @molcure]

↓詳細はこちら
https://t.co/xlppGTx6hi

[Molcure Inc. @molcure]

3/26(木)10:00、順天堂大学講演会「AI創薬の最前線とエコシステムの未来」にMOLCURE代表 玉木が登壇します。AI駆動型科学による抗体・ペプチド創薬の最新研究とエコシステムの展望を紹介します。

[Molcure Inc. @molcure]

Details & registration: https://t.co/xlppGTx6hi

[Molcure Inc. @molcure]

On Mar 26 at 10:00, MOLCURE CEO Satoshi Tamaki will speak at Juntendo University on the frontier of AI-driven drug discovery. Talk in Japanese.